Pharmaceutical care on a heart failure patient combined with pulmonary fungal infection after mitral valve replacement surgery due to rheumatic heart disease
CHEN Xing-wei
ZHENG Ying-li
WANG Ran-ran
Abstract：One 67-year-old female patient with pulmonary infection, respiratory failure and other diseases was hospitalized primary for rheumatic heart disease and heart failure after mitral valve replacement surgery. The patient was treated by non-invasive mechanical ventilation, and anticoagulation, cardiotonic, diuretic, eliminating sputum, antiasthmatic as well as anti-infectious drugs. The heart failure symptom of the patient improved, however the lung infection aggravated. Fungal infection was considered according to the clinical signs and laboratory examinations of the patient. Pharmaceutical cares were given to the patient by clinical pharmacists in respect of the selection and dose adjustment of the antifungal agent, fluctuations analysis of the international normalized ratio (INR) due to the interactions between the warfarin and other drugs, the treatment of electrolyte imbalance after long-term use of thiazide diuretic and monitoring the side effect of the antibacterials such as QT interval prolonged, ventricle speed torsade de pointe, etc. After 15-day treatment, the patient's symptom improved, and the patient was transferred to the general ward for further treatments.
Keywords：Rheumatic heart diseaseMitral valve replacementHeart failureFungal infectionClinical pharmacistPharmaceutical care
Publication Date：2015-01-01
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：3( 24-26 )